SHINGRIX: a new paradigm in shingles prevention

GSK's portfolio of vaccines have been helping to protect people from a range of serious diseases for well over 100 years. We are pleased to invite you to an educational meeting which aims to enhance your knowledge of herpes zoster (shingles) and its prevention with SHINGRIX.

Agenda

6:30pm - Registration

7:00pm - Impact of shingles including a case study

8:00pm - Mains

8:40pm - Q&A

9:00pm - Meeting close

Speaker - Professor Paul Van Buynder

Professor Van Buynder is a Public Health Physician who holds a Professorship at Griffith University in the School of Medicine, with a focus on vaccinology. He has worked in senior health positions in a number of Australian states, in Canada and in the Centre for Infections in London managing respiratory disease programs for the United Kingdom. His research interests are in new vaccines and vaccine hesitancy.

He is the author of over 60 book chapters and refereed journal articles. He has special interests in children and vaccines, in influenza and in other infections.

REGISTRATION INFORMATION

If you wish to register for this event, please contact Michael from GSK and request a registration form: michael.x.shewan@gsk.com or 0406 686 402.

RSVP on or before Friday, 21st of October.